Mesenchymal Stem Cell-Derived Neural Progenitors Attenuate Proinflammatory Microglial Activation Via Paracrine Mechanisms

References

• Correale J , GaitanMI , YsrraelitMC , FiolMP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain140(3), 527–546 (2017).
   PubMed Web of Science ®Google Scholar
• Harris VK , StarkJ , VyshkinaTet al. Phase I trial of intrathecal mesenchymal stem cell-derived neural progenitors in progressive multiple sclerosis. EBioMedicine29, 23–30 (2018).
   PubMed Web of Science ®Google Scholar
• Harris VK , FaroquiR , VyshkinaT , SadiqSA. Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis. Stem Cells Transl. Med.1(7), 536–547 (2012).
   PubMed Web of Science ®Google Scholar
• Harris VK , YanQJ , VyshkinaT , SahabiS , LiuX , SadiqSA. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis. J. Neurol. Sci.313(1-2), 167–177 (2012).
   PubMed Web of Science ®Google Scholar
• Harris VK , StarkJW , YangS , ZankerS , TuddenhamJ , SadiqSA. Mesenchymal stem cell-derived neural progenitors in progressive MS: two-year follow-up of a phase I study. Neurol. Neuroimmunol. Neuroinflamm.8(1), e928 (2021).
   PubMed Web of Science ®Google Scholar
• Conductier G , BlondeauN , GuyonA , NahonJL , RovereC. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol.224(1-2), 93–100 (2010).
   PubMed Web of Science ®Google Scholar
• Mcmanus C , BermanJW , BrettFM , StauntonH , FarrellM , BrosnanCF. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J. Neuroimmunol.86(1), 20–29 (1998).
   PubMed Web of Science ®Google Scholar
• Simpson JE , NewcombeJ , CuznerML , WoodroofeMN. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol.84(2), 238–249 (1998).
   PubMed Web of Science ®Google Scholar
• Guerrero BL , SicotteNL. Microglia in multiple sclerosis: friend or foe? Front. Immunol.11, 374 (2020).
   PubMedGoogle Scholar
• Jha MK , LeeWH , SukK. Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders. Biochem. Pharmacol.103, 1–16 (2016).
   PubMed Web of Science ®Google Scholar
• O’Loughlin E , MadoreC , LassmannH , ButovskyO. Microglial phenotypes and functions in multiple sclerosis. Cold Spring Harb. Perspect. Med.8(2), a028993 (2018).
   PubMed Web of Science ®Google Scholar
• Masuda T , SankowskiR , StaszewskiOet al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature566(7744), 388–392 (2019).
   PubMed Web of Science ®Google Scholar
• Yong HYF , YongVW. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis. Nat. Rev. Neurol.18(1), 40–55 (2022).
   PubMed Web of Science ®Google Scholar
• Barati S , RagerdiKashani I , MoradiFet al. Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model. J. Cell. Biochem.120(8), 13952–13964 (2019).
   PubMed Web of Science ®Google Scholar
• Giunti D , ParodiB , UsaiCet al. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells30(9), 2044–2053 (2012).
   PubMed Web of Science ®Google Scholar
• Li Z , LiuF , HeX , YangX , ShanF , FengJ. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int. Immunopharmacol.67, 268–280 (2019).
   PubMed Web of Science ®Google Scholar
• Noh MY , LimSM , OhKWet al. Mesenchymal stem cells modulate the functional properties of microglia via TGF-β secretion. Stem Cells Transl. Med.5(11), 1538–1549 (2016).
   PubMed Web of Science ®Google Scholar
• Ooi YY , RamasamyR , RahmatZet al. Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide. Int. Immunopharmacol.10(12), 1532–1540 (2010).
   PubMed Web of Science ®Google Scholar
• Tahmasebi F , PasbakhshP , BaratiS , MadadiS , KashaniIR. The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model. J. Cell. Physiol.236(5), 3552–3564 (2021).
   PubMed Web of Science ®Google Scholar
• Yan K , ZhangR , SunCet al. Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation. PLOS ONE8(12), e84116 (2013).
   PubMed Web of Science ®Google Scholar
• Yang F , LiWB , QuYWet al. Bone marrow mesenchymal stem cells induce M2 microglia polarization through PDGF-AA/MANF signaling. World J. Stem. Cells12(7), 633–658 (2020).
   PubMed Web of Science ®Google Scholar
• Lara-Reyna S , ScamblerT , HolbrookJet al. Metabolic reprograming of cystic fibrosis macrophages via the IRE1α arm of the unfolded protein response results in exacerbated inflammation. Front. Immunol.10, 1789 (2019).
   PubMed Web of Science ®Google Scholar
• Douvaras P , SunB , WangMet al. Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Rep.8(6), 1516–1524 (2017).
   PubMed Web of Science ®Google Scholar
• Svoboda DS , BarrasaMI , ShuJet al. Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain. Proc. Natl Acad. Sci. USA116(50), 25293–25303 (2019).
   PubMed Web of Science ®Google Scholar
• Horvath RJ , Nutile-McMenemyN , AlkaitisMS , DeleoJA. Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J. Neurochem.107(2), 557–569 (2008).
   PubMed Web of Science ®Google Scholar
• Janabi N . Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages. J. Immunol.168(9), 4747–4755 (2002).
   PubMed Web of Science ®Google Scholar
• Bohlen CJ , BennettFC , TuckerAF , CollinsHY , MulinyaweSB , BarresBA. Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures. Neuron94(4), 759–773; e758 (2017).
   PubMed Web of Science ®Google Scholar
• Gosselin D , SkolaD , CoufalNGet al. An environment-dependent transcriptional network specifies human microglia identity. Science356(6344), eaal3222 (2017).
   PubMed Web of Science ®Google Scholar
• Hasselmann J , Blurton-JonesM. Human iPSC-derived microglia: a growing toolset to study the brain’s innate immune cells. Glia68(4), 721–739 (2020).
   PubMed Web of Science ®Google Scholar
• Fortune AJ , FletcherJL , BlackburnNB , YoungKM. Using MS induced pluripotent stem cells to investigate MS aetiology. Mult. Scler. Relat. Disord.63, 103839 (2022).
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium . Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science365(6460), eaav7188 (2019).
   PubMed Web of Science ®Google Scholar
• Abud EM , RamirezRN , MartinezESet al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron94(2), 278–293; e9 (2017).
   PubMed Web of Science ®Google Scholar
• Lively S , SchlichterLC. Microglia responses to pro-inflammatory stimuli (LPS, IFNγ+TNFα) and reprogramming by resolving cytokines (IL-4, IL-10). Front. Cell. Neurosci.12, 215 (2018).
   PubMed Web of Science ®Google Scholar
• Lund S , ChristensenKV , HedtjarnMet al. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J. Neuroimmunol.180(1-2), 71–87 (2006).
   PubMed Web of Science ®Google Scholar
• Benveniste EN , BenosDJ. TNF-γ- and IFN-γ-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J.9(15), 1577–1584 (1995).
   PubMed Web of Science ®Google Scholar
• Spittau B , DokalisN , PrinzM. The role of TGFβ signaling in microglia maturation and activation. Trends Immunol.41(9), 836–848 (2020).
   PubMed Web of Science ®Google Scholar
• Tang Y , LeW. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol. Neurobiol.53(2), 1181–1194 (2016).
   PubMed Web of Science ®Google Scholar
• Tzavlaki K , MoustakasA. TGF-β signaling. Biomolecules10(3), 487 (2020).
   PubMed Web of Science ®Google Scholar
• Nolta JA , GalipeauJ , PhinneyDG. Improving mesenchymal stem/stromal cell potency and survival: proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congres de Montreal, organized by the ISCT MSC Scientific Committee. Cytotherapy22(3), 123–126 (2020).
   PubMed Web of Science ®Google Scholar
• Berry JD , CudkowiczME , WindebankAJet al. NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results. Neurology93(24), e2294–e2305 (2019).
   PubMed Web of Science ®Google Scholar
• Oh KW , NohMY , KwonMSet al. Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis. Ann. Neurol.84(3), 361–373 (2018).
   PubMed Web of Science ®Google Scholar
• Masuda T , SankowskiR , StaszewskiO , PrinzM. Microglia heterogeneity in the single-cell era. Cell Rep.30(5), 1271–1281 (2020).
   PubMed Web of Science ®Google Scholar